Search Result
List
2015-09-01 - 2018-12-31
Phase II
-
Condition/Disease
Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
-
Test Drug
Durvalumab (MEDI4736), Tremelimumab
Participate Sites
3Sites
Terminated3Sites
Division of Hematology & Oncology
Division of Hematology & Oncology
2017-02-17 - 2020-12-17
Phase III
-
Condition/Disease
Crohn’s Disease
-
Test Drug
Filgotinib
Participate Sites
13Sites
Recruiting8Sites
Terminated3Sites
Division of General Internal Medicine
2015-08-15 - 2018-03-28
Phase III
-
Condition/Disease
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
-
Test Drug
MEDI4736
Participate Sites
5Sites
Terminated5Sites
Division of Hematology & Oncology
2015-08-01 - 2016-07-31
Phase I
-
Condition/Disease
-
Test Drug
Participate Sites
1Sites
Terminated1Sites
Division of Nuclear Medicine
2015-08-01 - 2018-07-31
Phase II
-
Condition/Disease
-
Test Drug
Participate Sites
1Sites
Terminated1Sites
Division of Neurology
2017-08-01 - 2020-07-31
Phase II
-
Condition/Disease
-
Test Drug
Participate Sites
1Sites
Suspended1Sites
Division of Nuclear Medicine
2018-01-01 - 2019-12-31
Others
-
Condition/Disease
Angina
-
Test Drug
Ranolazine
Participate Sites
3Sites
Terminated3Sites
Division of Cardiovascular Diseases
2018-06-01 - 2022-09-30
Phase III
-
Condition/Disease
Small cell lung cancer
-
Test Drug
ONIVYDE
Participate Sites
5Sites
Recruiting5Sites
Division of Hematology & Oncology
2018-03-01 - 2021-01-04
Phase II
-
Condition/Disease
Previously Treated Unresectable Hepatocellular Carcinoma
-
Test Drug
BGB-A317
Participate Sites
6Sites
Recruiting5Sites
Terminated1Sites
Division of General Internal Medicine
Division of Hematology & Oncology
2017-04-01 - 2019-10-31
Phase II
-
Condition/Disease
Systemic Lupus Erythematosus (SLE)
-
Test Drug
GDC-0853
Participate Sites
8Sites
Terminated6Sites
Division of Rheumatology
